Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the End Of Life topic
No spam. Unsubscribe anytime.
Committee hears emotional, divided testimony on medical aid-in-dying bill
Summary
House Bill 5219 would create a legal mechanism for a terminally ill, capacitated adult to request prescribed medication to end their life; the Judiciary Committee heard hours of testimony from survivors, clinicians and legal advocates.
Get email alerts on the End Of Life topic
No spam. Unsubscribe anytime.
The House Judiciary Committee held an extended hearing on House Bill 5219, a measure that would establish a legal process for terminally ill patients (those with a physician’s prognosis of six months or less to live) to request and receive prescribed medication to end their life. Representative Ajello sponsored the bill and introduced it as comparable to laws enacted in other jurisdictions.
Supporters included Jennifer Hopkins McDowell, who gave personal testimony about a family history of a degenerative neurological disorder and urged the committee to allow patients to decide when to end protracted suffering. Kira (Cara) Phillips testified about her mother’s suicide after a long cancer course and advocated the bill as prevention against violent or unsupported ends. Jennifer Brown, a hospice nurse, described witnessing severe end-of-life suffering she called “torturous” for some patients and emphasized hospice care and the limited subset of patients the bill would affect. Multiple other witnesses and organizations signed in either supporting or opposing the bill.
Opponents included Katie Kelly, a policy counsel with Americans United for Life, who argued the bill lacks adequate safeguards because (she said) the language does not require formal clinical mental-health evaluations in all cases and does not define an objective standard for assessing impaired judgment. She said the bill’s referral provision could leave many patients without substantive psychiatric assessment and cited data showing comorbidity of depression among chronically ill and terminal patients.
A medical student, John Murphy, testified his opposition rooted in the Hippocratic duty to “do no harm,” arguing physicians should not participate in prescribing lethal medication. Representative members asked questions about safeguards, the grief process after a terminal prognosis, residency/physician relationship duration and whether primary-care physicians would be sufficient to evaluate capacity. Representative Jay (committee member) noted the bill contains an explicit exemption allowing physicians to decline participation on conscience grounds.
Committee members and public witnesses debated multiple issues: whether primary-care providers routinely assess depression, whether depression and grief are being adequately screened and treated before prescribing lethal medication, how long the effects of such drugs can take, and whether the law would enable out-of-state patients to participate. Several witnesses cited Oregon and other states’ experience; supporters argued the number of patients using such options is small and the policy can prevent violent or traumatic deaths.
The transcript records extensive testimony and questioning but does not show the committee taking a final vote during this session.
